WEKO3
アイテム
{"_buckets": {"deposit": "2a6a8571-6030-4293-b294-b219c7bd0872"}, "_deposit": {"created_by": 1, "id": "72759", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "72759"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00072759", "sets": ["28"]}, "author_link": ["716651", "716648", "716649", "716658", "716644", "716656", "716653", "716654", "716647", "716646", "716650", "716652", "716645", "716655", "716657"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2018-04-23", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background and Aims: Capturing host antitumor responses to combinatorial immunotherapy remains a major challenge. From the standpoint of immunology, cancer immunotherapy is considered as a “double edged sword” in that it can trigger two opposite immunologic processes to limit potential toxicity associated with excessive response [1]. So tracking its opposite immune regulatory-mechanisms has potential as surrogates for defining the complex scenarios. In this study, we developed a small-molecular positron emission tomography/computed tomography (PET/CT) method targeting the checkpoint protein, IDO1, in tumor-bearing hosts to address this challenge. \n\\nMethods: Leveraging the very short-lived positron emitter carbon-11 (11C; half-life: 20.4 min) to label a small molecule IDO1 inhibitor, levorotary (L) form of 1-methyl-tryptophan (1MTrp), we developed a radioprobe 1-N-11C-methyl-L-tryptophan (11C-L-1MTrp) [2]. Using PET/CT with 11C-L-1MTrp, we specifically and serially monitored IDO1 changes to reveal the antitumor immune response in melanoma-bearing immunocompetent mice treated with immunotherapy combinatorial chemotherapy. Animal studies were approved by the Animal Ethics Committee of the National Institutes for Quantum and Radiological Science and Technology.\n\\nResults: On combining the 11C-L-1MTrp and the imaging power of PET/CT, we observed that IDO1 exhibited dynamic alterations in mesenteric lymph nodes (MLN) and the caput of the epididymis, and observed a connection between active responses to combinatorial immunotherapy in immunocompetent mice. These imaging markers exhibited an empirical cut-off value of 7.023 %ID/g for radioactivity in MLN, which provided an early-on-treatment indicator with 97.92 % specificity. A cut-off value of 8.313 %ID/g in the epididymis offered a sensitivity of 100 % as an index of immune exhaustion. \n\\nConclusion: 11C-L-1MTrp-PET/CT provided a visual method to capture the dynamics of host responses to combinatorial immunotherapies, with near-term clinical application. \n\\nReferences: [1]. Pardoll DM. Nature Rev. Cancer. 2012, 12, 252. [2] Xie, L. et al. Sci. Rep.2015, 5,16417.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "12th World Congress of the World Federation of Nuclear Medicine and Biology", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Xie, Lin"}], "nameIdentifiers": [{"nameIdentifier": "716644", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shimokawa, Takashi"}], "nameIdentifiers": [{"nameIdentifier": "716645", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Yiding"}], "nameIdentifiers": [{"nameIdentifier": "716646", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Jiang, Cuiping"}], "nameIdentifiers": [{"nameIdentifier": "716647", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Wakizaka, Hidekatsu"}], "nameIdentifiers": [{"nameIdentifier": "716648", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kumata, Katsushi"}], "nameIdentifiers": [{"nameIdentifier": "716649", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nengaki, Nobuki"}], "nameIdentifiers": [{"nameIdentifier": "716650", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Ming-Rong"}], "nameIdentifiers": [{"nameIdentifier": "716651", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "謝 琳", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "716652", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "下川 卓志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "716653", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "張 一鼎", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "716654", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "脇坂 秀克", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "716655", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "熊田 勝志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "716656", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "念垣 信樹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "716657", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "張 明栄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "716658", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Visualizing the dynamics of checkpoint protein IDO1 reveals host antitumor responses activated by a combination of immunotherapy and chemotherapy with 11C-L-1MTrp PET", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Visualizing the dynamics of checkpoint protein IDO1 reveals host antitumor responses activated by a combination of immunotherapy and chemotherapy with 11C-L-1MTrp PET"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/72759", "pubdate": {"attribute_name": "公開日", "attribute_value": "2018-04-27"}, "publish_date": "2018-04-27", "publish_status": "0", "recid": "72759", "relation": {}, "relation_version_is_last": true, "title": ["Visualizing the dynamics of checkpoint protein IDO1 reveals host antitumor responses activated by a combination of immunotherapy and chemotherapy with 11C-L-1MTrp PET"], "weko_shared_id": -1}
Visualizing the dynamics of checkpoint protein IDO1 reveals host antitumor responses activated by a combination of immunotherapy and chemotherapy with 11C-L-1MTrp PET
https://repo.qst.go.jp/records/72759
https://repo.qst.go.jp/records/72759196e161c-77dc-47a2-b4ba-3affd8a8fadd
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-04-27 | |||||
タイトル | ||||||
タイトル | Visualizing the dynamics of checkpoint protein IDO1 reveals host antitumor responses activated by a combination of immunotherapy and chemotherapy with 11C-L-1MTrp PET | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Xie, Lin
× Xie, Lin× Shimokawa, Takashi× Zhang, Yiding× Jiang, Cuiping× Wakizaka, Hidekatsu× Kumata, Katsushi× Nengaki, Nobuki× Zhang, Ming-Rong× 謝 琳× 下川 卓志× 張 一鼎× 脇坂 秀克× 熊田 勝志× 念垣 信樹× 張 明栄 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background and Aims: Capturing host antitumor responses to combinatorial immunotherapy remains a major challenge. From the standpoint of immunology, cancer immunotherapy is considered as a “double edged sword” in that it can trigger two opposite immunologic processes to limit potential toxicity associated with excessive response [1]. So tracking its opposite immune regulatory-mechanisms has potential as surrogates for defining the complex scenarios. In this study, we developed a small-molecular positron emission tomography/computed tomography (PET/CT) method targeting the checkpoint protein, IDO1, in tumor-bearing hosts to address this challenge. \nMethods: Leveraging the very short-lived positron emitter carbon-11 (11C; half-life: 20.4 min) to label a small molecule IDO1 inhibitor, levorotary (L) form of 1-methyl-tryptophan (1MTrp), we developed a radioprobe 1-N-11C-methyl-L-tryptophan (11C-L-1MTrp) [2]. Using PET/CT with 11C-L-1MTrp, we specifically and serially monitored IDO1 changes to reveal the antitumor immune response in melanoma-bearing immunocompetent mice treated with immunotherapy combinatorial chemotherapy. Animal studies were approved by the Animal Ethics Committee of the National Institutes for Quantum and Radiological Science and Technology. \nResults: On combining the 11C-L-1MTrp and the imaging power of PET/CT, we observed that IDO1 exhibited dynamic alterations in mesenteric lymph nodes (MLN) and the caput of the epididymis, and observed a connection between active responses to combinatorial immunotherapy in immunocompetent mice. These imaging markers exhibited an empirical cut-off value of 7.023 %ID/g for radioactivity in MLN, which provided an early-on-treatment indicator with 97.92 % specificity. A cut-off value of 8.313 %ID/g in the epididymis offered a sensitivity of 100 % as an index of immune exhaustion. \nConclusion: 11C-L-1MTrp-PET/CT provided a visual method to capture the dynamics of host responses to combinatorial immunotherapies, with near-term clinical application. \nReferences: [1]. Pardoll DM. Nature Rev. Cancer. 2012, 12, 252. [2] Xie, L. et al. Sci. Rep.2015, 5,16417. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 12th World Congress of the World Federation of Nuclear Medicine and Biology | |||||
発表年月日 | ||||||
日付 | 2018-04-23 | |||||
日付タイプ | Issued |